Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Satoh

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Endocrine Journal|October 6, 2007
Clinical significance of 1-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosisTakafumi Majima, Yasato Komatsu, Akira Shimatsu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2009
Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndromeNoriko Satoh, Akira Shimatsu, Kazuhiko Kotani, et al.
Endocrine Journal|January 26, 2008
Increased bone turnover in patients with hypercholesterolemiaTakafumi Majima, Akira Shimatsu, Yasato Komatsu, et al.
Endocrine Journal|January 26, 2008
Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosisTakafumi Majima, Yasato Komatsu, Akira Shimatsu, et al.
Endocrine Journal|January 12, 2008
Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosisTakafumi Majima, Akira Shimatsu, Yasato Komatsu, et al.
Diabetes Care|December 31, 2009
Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazoneNoriko Satoh, Akira Shimatsu, Akihiro Himeno, et al.
Journal of Bone and Mineral Metabolism|February 28, 2008
Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosisTakafumi Majima, Akira Shimatsu, Noriko Satoh, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 22, 2010
[Limb-girdle muscular dystrophy type 2M with adult-onset loss of ambulation. A case report]Yoshiyuki Kondo, Madoka Mori-Yoshimura, Yukiko K Hayashi, et al.
Diabetes Care|December 29, 2006
Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndromeNoriko Satoh, Akira Shimatsu, Kazuhiko Kotani, et al.
Journal of Bone and Mineral Metabolism|February 3, 2009
Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational studyTakafumi Majima, Akira Shimatsu, Yasato Komatsu, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Endocrine Journal|October 6, 2007
Clinical significance of 1-year treatment with raloxifene on bone and lipid metabolism in Japanese postmenopausal women with osteoporosisTakafumi Majima, Yasato Komatsu, Akira Shimatsu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 19, 2009
Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndromeNoriko Satoh, Akira Shimatsu, Kazuhiko Kotani, et al.
Endocrine Journal|January 26, 2008
Increased bone turnover in patients with hypercholesterolemiaTakafumi Majima, Akira Shimatsu, Yasato Komatsu, et al.
Endocrine Journal|January 26, 2008
Efficacy of combined treatment with raloxifene and alfacalcidol on bone density and biochemical markers of bone turnover in postmenopausal osteoporosisTakafumi Majima, Yasato Komatsu, Akira Shimatsu, et al.
Endocrine Journal|January 12, 2008
Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosisTakafumi Majima, Akira Shimatsu, Yasato Komatsu, et al.
Diabetes Care|December 31, 2009
Unbalanced M1/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazoneNoriko Satoh, Akira Shimatsu, Akihiro Himeno, et al.
Journal of Bone and Mineral Metabolism|February 28, 2008
Three-month changes in bone turnover markers and bone mineral density response to raloxifene in Japanese postmenopausal women with osteoporosisTakafumi Majima, Akira Shimatsu, Noriko Satoh, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 22, 2010
[Limb-girdle muscular dystrophy type 2M with adult-onset loss of ambulation. A case report]Yoshiyuki Kondo, Madoka Mori-Yoshimura, Yukiko K Hayashi, et al.
Diabetes Care|December 29, 2006
Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndromeNoriko Satoh, Akira Shimatsu, Kazuhiko Kotani, et al.
Journal of Bone and Mineral Metabolism|February 3, 2009
Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational studyTakafumi Majima, Akira Shimatsu, Yasato Komatsu, et al.
Pageof 18